|
|
3030 Banker Hill St., Ste. 100
San Diego, CA 92109 USA
phone:(858) 777-2800
fax:(858) 777-2810
|
|
| Symbol |
Private |
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.targetedmolecules.com
|
|
|
|
 |
| Summary Description |
| Antibody therapeutics in the Selective Adhesion Molecule Inhibitors class of drugs. |
|
| Management |
| Elias Lazarides, Ph.D., President and CEO; Paul Cayer, SVP, Business Development and CFO; Catherine Woods, Ph.D., Executive Director, Biological Research and Extramural Affairs |
| |
|
|
| |
|
| Keywords |
| psoriasis, multiple sclerosis, rheumatoid arthritis, cancer, Selective Adhesion Molecule Inhibitor, therapeutics |
|
|
|
| Description |
|
Targeted Molecules Corp. develops antibody therapeutics in the validated class of drugs known as Selective Adhesion Molecule Inhibitors. |
|
| Technology / Differentiation |
| Selective Adhesion Molecule Inhibitor drugs target psoriasis, multiple sclerosis, rheumatoid arthritis, and cancer. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members